Total Payments
$7,644
2024 Payments
$1,436
Companies
34
Transactions
415
Medicare Patients
2,471
Medicare Billing
$229,655
Payment Breakdown by Category
Food & Beverage$7,315 (95.7%)
Education$328.92 (4.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,315 | 411 | 95.7% |
| Education | $328.92 | 4 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,638 | 97 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,248 | 62 | $0 (2024) |
| Janssen Biotech, Inc. | $746.40 | 36 | $0 (2024) |
| Lilly USA, LLC | $696.20 | 38 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $605.84 | 35 | $0 (2024) |
| PFIZER INC. | $576.18 | 28 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $330.08 | 19 | $0 (2020) |
| UCB, Inc. | $271.99 | 14 | $0 (2024) |
| Amgen Inc. | $264.22 | 11 | $0 (2024) |
| Aqua Pharmaceuticals | $200.80 | 15 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,436 | 78 | ABBVIE INC. ($476.70) |
| 2023 | $1,560 | 95 | AbbVie Inc. ($393.73) |
| 2022 | $1,020 | 51 | ABBVIE INC. ($285.67) |
| 2021 | $713.48 | 38 | Janssen Biotech, Inc. ($203.39) |
| 2020 | $516.02 | 22 | Novartis Pharmaceuticals Corporation ($153.63) |
| 2019 | $792.97 | 46 | Novartis Pharmaceuticals Corporation ($286.53) |
| 2018 | $726.93 | 40 | Novartis Pharmaceuticals Corporation ($272.85) |
| 2017 | $879.08 | 45 | Novartis Pharmaceuticals Corporation ($234.15) |
All Payment Transactions
415 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Immunology | ||||||
| 12/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.73 | General |
| Category: Immunology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.13 | General |
| Category: Immunology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.45 | General |
| Category: Immunology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.90 | General |
| Category: Immunology | ||||||
| 12/06/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Inflammation & Immunology | ||||||
| 11/22/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.60 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: Immunology | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.84 | General |
| Category: Immunology | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.00 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Inflammation & Immunology | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Fidia Pharma USA Inc. | — | Food and Beverage | In-kind items and services | $15.93 | General |
| 09/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.80 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.44 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.42 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 723 | 1,093 | $188,882 | $66,046 |
| 2022 | 13 | 604 | 933 | $144,759 | $56,867 |
| 2021 | 14 | 604 | 955 | $148,730 | $60,489 |
| 2020 | 12 | 540 | 853 | $123,090 | $46,253 |
Total Patients
2,471
Total Services
3,834
Medicare Billing
$229,655
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 287 | $60,694 | $22,156 | 36.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 86 | 102 | $28,057 | $9,769 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 79 | $23,575 | $8,658 | 36.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $15,708 | $5,354 | 34.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 75 | 106 | $17,114 | $5,087 | 29.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 59 | 65 | $16,014 | $4,945 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $8,601 | $3,286 | 38.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 45 | $5,999 | $2,138 | 35.6% |
| 10040 | Acne surgery | Office | 2023 | 14 | 15 | $4,251 | $1,635 | 38.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 28 | 36 | $4,968 | $1,554 | 31.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 47 | 207 | $3,304 | $1,311 | 39.7% |
| 87101 | Fungal culture (mold or yeast) of skin, hair, or nail | Office | 2023 | 12 | 14 | $476.00 | $105.84 | 22.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 31 | 56 | $122.06 | $47.11 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 173 | 223 | $38,036 | $17,357 | 45.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 91 | 104 | $25,922 | $10,695 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 77 | $17,894 | $8,752 | 48.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 51 | 51 | $12,480 | $4,650 | 37.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 60 | 85 | $12,679 | $3,432 | 27.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 33 | 37 | $10,200 | $2,890 | 28.3% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2022 | 17 | 46 | $6,618 | $1,815 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,805 | $1,772 | 46.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 31 | 33 | $3,627 | $1,743 | 48.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 11 | 11 | $2,950 | $1,345 | 45.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 17 | 27 | $3,470 | $1,213 | 35.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 33 | 180 | $6,500 | $1,161 | 17.9% |
About Dr. John Troccoli, MD
Dr. John Troccoli, MD is a Dermatology healthcare provider based in Fresh Meadows, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861492977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Troccoli, MD has received a total of $7,644 in payments from pharmaceutical and medical device companies, with $1,436 received in 2024. These payments were reported across 415 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($7,315).
As a Medicare-enrolled provider, Troccoli has provided services to 2,471 Medicare beneficiaries, totaling 3,834 services with total Medicare billing of $229,655. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Fresh Meadows, NY
- Active Since 07/29/2005
- Last Updated 10/10/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1861492977
Products in Payments
- COSENTYX (Biological) $1,136
- SKYRIZI (Biological) $792.12
- TALTZ (Drug) $637.73
- Sotyktu (Drug) $605.84
- EUCRISA (Drug) $507.09
- TREMFYA (Drug) $436.14
- RINVOQ (Biological) $393.24
- Humira (Biological) $340.43
- Otezla (Drug) $216.17
- Cimzia (Drug) $191.98
- DUPIXENT (Biological) $173.84
- REMICADE (Biological) $167.29
- VTAMA (Drug) $165.55
- ILUMYA (Biological) $158.05
- HUMIRA (Biological) $88.59
- Bimzelx (Biological) $80.01
- STELARA (Biological) $74.99
- CIBINQO (Drug) $69.09
- Tremfya (Drug) $67.98
- PRAMOSONE (Drug) $63.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fresh Meadows
Suzanne Friedler, Md, MD
Dermatology — Payments: $58,342
Dermatology $58,342
Stanley Newfield, Md, MD
Dermatology — Payments: $29,054
Dermatology $29,054
Lance Barazani, Md, MD
Dermatology — Payments: $15,841
Dermatology $15,841
Joshua Fox, Md, MD
Dermatology — Payments: $8,943
Dermatology $8,943
Meryl Blecker Joerg, Md, MD
Dermatology — Payments: $8,494
Dermatology $8,494
Francis Dispaltro, Md, MD
Dermatology — Payments: $4,467
Dermatology $4,467